Compare SLQT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | INCR |
|---|---|---|
| Founded | 1985 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 58.6M |
| IPO Year | 2020 | 2021 |
| Metric | SLQT | INCR |
|---|---|---|
| Price | $6.28 | $3.63 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $42.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 9.5K |
| Earning Date | 11-04-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,618,499,000.00 | N/A |
| Revenue This Year | N/A | $217.52 |
| Revenue Next Year | $4.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.02 | N/A |
| 52 Week Low | $0.30 | $0.68 |
| 52 Week High | $8.07 | $6.10 |
| Indicator | SLQT | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 92.39 | 35.49 |
| Support Level | $0.63 | $0.81 |
| Resistance Level | N/A | $4.19 |
| Average True Range (ATR) | 0.27 | 0.25 |
| MACD | 0.60 | -0.00 |
| Stochastic Oscillator | 77.27 | 31.67 |
SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.